Displaying drugs 2151 - 2175 of 2780 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Oxilofrine | 181.235 C10H15NO2 |  | An amphetamine used to treat a cough associated with inflamed mucosa. | Alcohols / Amines / Amino Alcohols / Antitussive Agents / Ethylamines / Phenethylamines / Propanolamines / Propanols |
| Lifitegrast | 615.48 C29H24Cl2N2O7S |  | A medication used to treat dry eye disease. | Lymphocyte Function-Associated Antigen-1 / Lymphocyte Function-Associated Antigen-1 Antagonist / Ophthalmic Solutions |
| Velpatasvir | 883.019 C49H54N8O8 |  | A NS5A inhibitor used to treat chronic hepatitis C infections in patients without cirrhosis or with compensated cirrhosis. | Antivirals for treatment of HCV infections |
| Rupatadine | 415.97 C26H26ClN3 |  | A selective histamine H1 receptor antagonist and platelet activating factor (PAF) antagonist used to treat allergic rhinitis. | Platelet Activating Factor, antagonists & inhibitors |
| Gestrinone | 308.4141 C21H24O2 |  | Endometriosis with or without accompanying sterility. Treatment is limited to a single course of 6 months duration per lifetime [L1699, L1700]. | Antigonadotropins and Similar Agents |
| Dehydrocholic acid | 402.531 C24H34O5 |  | No approved therapeutic indications. | Cholagogues and Choleretics / Cholic Acids |
| Laropiprant | 435.89 C21H19ClFNO4S |  | Laropiprant is an ingredient in the EMA-withdrawn product Pelzont. | Heterocyclic Compounds, Fused-Ring |
| Temoporfin | 680.764 C44H32N4O4 |  | A photosensitizer used to treat squamous cell carcinomas of the head and neck. | Photosensitizing Agents / Sensitizers Used in Photodynamic/radiation Therapy |
| Opicapone | 413.17 C15H10Cl2N4O6 |  | A catechol-O-methyltransferase inhibitor used as an adjunct treatment for Parkinson's Disease in adults currently receiving levodopa and a dopa decarboxylase inhibitor. | COMT Inhibitors |
| Isavuconazole | 437.47 C22H17F2N5OS |  | Indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [FDA Label]. Indicated for patients 18 years of age and older for the treatment of... | Triazole and tetrazole derivatives / Triazole Derivatives |
| Colestilan chloride | (C7H11N2O)n.Cl |  | Colestilan is an ingredient in the EMA-withdrawn product BindRen. | Drugs for Treatment of Hyperkalemia and Hyperphosphatemia |
| Tocofersolan | C33H54O5(C2H4O)n |  | A derivative of alpha tocopherol used to treat vitamin E deficiencies. | Drug Carriers |
| Nomegestrol | 328.452 C21H28O3 |  | Nomegestrol is an ingredient in the EMA-authorised product Zoely. | Pregnadien Derivatives / Progestogens and Estrogens, Sequential Preparations |
| Delamanid | 534.492 C25H25F3N4O6 |  | An antibiotic used to treat multidrug resistant tuberculosis. | Antiinfectives for Systemic Use / Antimycobacterials / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs for Treatment of Tuberculosis / Imidazoles / Moderate Risk QTc-Prolonging Agents / Nitro Compounds / QTc Prolonging Agents |
| Artenimol | 284.352 C15H24O5 |  | For the treatment of uncomplicated Plasmodium falciparum infection in adults, children, and infants aged 6 months and up weighing over 5 kg [FDA Label]. Used in combination with DB13941. | Artemisinin and derivatives |
| Amifampridine | 109.132 C5H7N3 |  | A voltage gated potassium channel blocker used to treat Lambert-Eaton myasthenic syndrome. | Potassium Channel Blockers |
| Vinflunine | 816.944 C45H54F2N4O8 |  | A vinca alkaloid used to treat advanced or metastatic transitional cell carcinoma of the urothelial tract after a platinum containing treatment has failed. | Vinca Alkaloids |
| Pitolisant | 295.85 C17H26ClNO |  | An antagonist and inverse agonist at the histamine H3 receptor that is used to treat narcolepsy in adults. | Drugs causing inadvertant photosensitivity / Receptors, Histamine H3 |
| Tafamidis | 308.116 C14H7Cl2NO3 |  | A medication used to treat transthyretin-mediated amyloidosis. | Anti-Inflammatory Agents |
| Tucatinib | 480.532 C26H24N8O2 |  | A kinase inhibitor used to treat certain types of unresectable/metastatic HER-2 positive breast cancer. | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors |
| Rebamipide | 370.79 C19H15ClN2O4 |  | A gastroprotective agent used in combination with other similar therapies (e.g. proton pump inhibitors) to treat gastritis and protect the gastric mucosa. | Anti-Ulcer Agents / Antioxidants / Enzyme Inhibitors |
| Latanoprostene bunod | 507.624 C27H41NO8 |  | A prostaglandin analog used to reduce ocular hypertension or treat open-angle glaucoma. | Prostaglandins, Synthetic |
| Curcumin | 368.3799 C21H20O6 |  | No approved therapeutic indications. | Antineoplastic Agents / Catechols / Coloring Agents / Diarylheptanoids / Enzyme Inhibitors |
| Triheptanoin | 428.61 C24H44O6 |  | Triheptanoin is a medium chain triglyceride indicated to provide calories and fatty acids to treat long chain fatty acid oxidation disorders. | Various Alimentary Tract and Metabolism Products |
| Treosulfan | 278.29 C6H14O8S2 |  | Treosulfan is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood. | Alkanesulfonates |
Displaying drugs 2151 - 2175 of 2780 in total